No abstract available
MeSH terms
-
Atherosclerosis / diagnosis
-
Atherosclerosis / etiology
-
Atherosclerosis / prevention & control*
-
Biomarkers / blood
-
Clinical Decision-Making
-
Cognition* / drug effects
-
Dyslipidemias / blood
-
Dyslipidemias / complications
-
Dyslipidemias / diagnosis
-
Dyslipidemias / drug therapy*
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
-
Lipids / blood*
-
Memory Disorders / complications*
-
Memory Disorders / diagnosis
-
Memory Disorders / psychology
-
Memory* / drug effects
-
Patient Selection
-
Risk Assessment
-
Risk Factors
-
Treatment Outcome
Substances
-
Biomarkers
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Lipids